Marvitense 20/5/12,5 mg 30 tablets

Marvitense 20/5/12,5 mg 30 tablets

Composition:

Active ingredients in one tablet:

• Olmesartan medoxomil - 20 mg
• Amlodipine - 5 mg
• Hydrochlorothiazide - 12.5 mg

Pharmacological properties:

• Olmesartan is an angiotensin II receptor blocker (sartan), reduces vascular resistance and blood pressure.
• Amlodipine is a calcium channel blocker, relaxes vascular smooth muscles, improves blood flow and reduces blood pressure.
• Hydrochlorothiazide is a thiazide diuretic, promotes the excretion of sodium and water, reducing the volume of circulating blood and lowering blood pressure.
The three components enhance each other's action, providing a persistent and pronounced decrease in blood pressure.

Indications for use:

• Arterial hypertension (in patients requiring combination therapy)
• Maintenance treatment in patients who have not achieved target pressure on monotherapy

Method of administration and dosage:

• Usually taken once a day, preferably at the same time of day.
• Tablets are taken orally with water, regardless of food intake.
• The dosage is prescribed by the doctor individually, based on the level of blood pressure and tolerance of the components.